M 1814 2'-(O-Methyl)guanosine |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
| Solid | |
| Screw cap v-vial | 1 mg $215 |
| M.W. 297.27 | 5 mg $565 |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1835 2'-(O-Methyl)guanosine, [8-3H(N)]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 297.27 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
M 1743 3'-(O-Methyl)guanosine |
|
| Click here for Typical Certificate of Analysis | |
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
| Solid | |
| Screw cap v-vial | 1 mg $215 |
| M.W. 297.27 | 5 mg $565 |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1794 3'-(O-Methyl)guanosine, [8-3H(N)]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 297.27 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1703 7-Methylguanosine 5'-triphosphate, [7-methyl-3H]- |
|
|
|
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 1 Ci(37 GBq/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
M.W. 538.21 for free acid  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1892 7-Methylguanosine 5'-triphosphate, [7-methyl,8-3H]- |
|
|
|
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| 10-30 Ci(0.370-1.11 TBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
M.W. 538.21 for free acid  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1918 7-Methylguanosine 5'-triphosphate, [8-3H(N)]- |
|
|
|
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 0.5 Ci(18.5 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 538.21 for free acid | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2753 2'-C-Methylguanosine, [guanine-8-14C]- |
|
|
|
|
| Ethanol:water (1:1) solution, 100 µCi/ml | |
| ≥ 50 mCi (1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 297.30 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |